Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 197

1.

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study.

Reilmann R, McGarry A, Grachev ID, Savola JM, Borowsky B, Eyal E, Gross N, Langbehn D, Schubert R, Wickenberg AT, Papapetropoulos S, Hayden M, Squitieri F, Kieburtz K, Landwehrmeyer GB; European Huntington's Disease Network; Huntington Study Group investigators.

Lancet Neurol. 2018 Dec 14. pii: S1474-4422(18)30391-0. doi: 10.1016/S1474-4422(18)30391-0. [Epub ahead of print]

PMID:
30563778
2.

Clinical and genetic characteristics of late-onset Huntington's disease.

Oosterloo M, Bijlsma EK, van Kuijk SM, Minkels F, de Die-Smulders CE; REGISTRY Investigators of the European Huntington's Disease Network; Registry Steering committee; Language coordinators; EHDN's associate site in Singapore.

Parkinsonism Relat Disord. 2018 Nov 29. pii: S1353-8020(18)30490-5. doi: 10.1016/j.parkreldis.2018.11.009. [Epub ahead of print]

PMID:
30528461
3.

Interrater Reliability of the Unified Huntington's Disease Rating Scale-Total Motor Score Certification.

Winder JY, Roos RAC, Burgunder JM, Marinus J, Reilmann R.

Mov Disord Clin Pract. 2018 Apr 15;5(3):290-295. doi: 10.1002/mdc3.12618. eCollection 2018 May-Jun.

PMID:
30363437
4.

Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations.

Mestre TA, Forjaz MJ, Mahlknecht P, Cardoso F, Ferreira JJ, Reilmann R, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT; Members of the Movement Disorder Society Committee on Rating Scales Development.

Mov Disord Clin Pract. 2018 Jan 3;5(2):111-117. doi: 10.1002/mdc3.12571. eCollection 2018 Mar-Apr.

5.

Quantitative Measurements of Motor Function in Alzheimer's Disease, Frontotemporal Dementia, and Dementia with Lewy Bodies: A Proof-of-Concept Study.

Jeppesen Kragh F, Bruun M, Budtz-Jørgensen E, Hjermind LE, Schubert R, Reilmann R, Nielsen JE, Hasselbalch SG.

Dement Geriatr Cogn Disord. 2018;46(3-4):168-179. doi: 10.1159/000492860. Epub 2018 Sep 26.

PMID:
30257254
6.

On the rise: Quantitative measures in Huntington's disease.

Reilmann R, Schubert R, Bohlen S, Sass C.

Mov Disord. 2018 Aug;33(8):1370-1371. doi: 10.1002/mds.27469. No abstract available.

PMID:
30230629
7.

Vocalisation as a Viable Assessment for Phenotyping Minipigs Transgenic for the Huntington Gene?

Rieke L, Schubert R, Matheis T, Muratori LM, Motlik J, Schramke S, Fels M, Kemper N, Schuldenzucker V, Reilmann R.

J Huntingtons Dis. 2018;7(3):269-278. doi: 10.3233/JHD-170284.

PMID:
30103340
8.

Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study.

McNulty P, Pilcher R, Ramesh R, Necuiniate R, Hughes A, Farewell D, Holmans P, Jones L; REGISTRY Investigators of the European Huntington's Disease Network .

J Huntingtons Dis. 2018;7(3):209-222. doi: 10.3233/JHD-170263.

PMID:
30103338
9.

Working Memory-Related Effective Connectivity in Huntington's Disease Patients.

Lahr J, Minkova L, Tabrizi SJ, Stout JC, Klöppel S, Scheller E; TrackOn-HD Investigators.

Front Neurol. 2018 Jun 4;9:370. doi: 10.3389/fneur.2018.00370. eCollection 2018.

10.

Minipigs as a Large-Brained Animal Model for Huntington's Disease: From Behavior and Imaging to Gene Therapy.

Reilmann R, Schuldenzucker V.

Methods Mol Biol. 2018;1780:241-266. doi: 10.1007/978-1-4939-7825-0_13.

PMID:
29856023
11.

Behavioral Assessment of Stress Compensation in Minipigs Transgenic for the Huntington Gene Using Cortisol Levels: A Proof-of-Concept Study.

Schuldenzucker V, Schubert R, Muratori LM, Freisfeld F, Rieke L, Matheis T, Schramke S, Motlik J, Kemper N, Radespiel U, Reilmann R.

J Huntingtons Dis. 2018;7(2):151-161. doi: 10.3233/JHD-180285.

PMID:
29843247
12.

Does arterial hypertension influence the onset of Huntington's disease?

Valcárcel-Ocete L, Fullaondo A, Alkorta-Aranburu G, García-Barcina M, Roos RAC, Hjermind LE, Saft C, Frontali M, Reilmann R, Rickards H; REGISTRY investigators of the European Huntington’s Disease Network (EHDN), Zubiaga AM, Aguirre A.

PLoS One. 2018 May 23;13(5):e0197975. doi: 10.1371/journal.pone.0197975. eCollection 2018.

13.

Testing a longitudinal compensation model in premanifest Huntington's disease.

Gregory S, Long JD, Klöppel S, Razi A, Scheller E, Minkova L, Johnson EB, Durr A, Roos RAC, Leavitt BR, Mills JA, Stout JC, Scahill RI, Tabrizi SJ, Rees G; Track-On investigators .

Brain. 2018 Jul 1;141(7):2156-2166. doi: 10.1093/brain/awy122.

14.

Huntington's disease: Current and future therapeutic prospects.

Kieburtz K, Reilmann R, Olanow CW.

Mov Disord. 2018 Jul;33(7):1033-1041. doi: 10.1002/mds.27363. Epub 2018 May 8. Review.

PMID:
29737569
15.

Pallidal deep brain stimulation in juvenile Huntington's disease: local field potential oscillations and clinical data.

Ferrea S, Groiss SJ, Elben S, Hartmann CJ, Dunnett SB, Rosser A, Saft C, Schnitzler A, Vesper J, Wojtecki L; Surgical Approaches Working Group of the European Huntington’s Disease Network (EHDN).

J Neurol. 2018 Jul;265(7):1573-1579. doi: 10.1007/s00415-018-8880-1. Epub 2018 May 3.

PMID:
29725840
16.

Objective assessment of gait and posture in premanifest and manifest Huntington disease - A multi-center study.

Beckmann H, Bohlen S, Saft C, Hoffmann R, Gerss J, Muratori L, Ringelstein EB, Landwehrmeyer GB, Reilmann R.

Gait Posture. 2018 May;62:451-457. doi: 10.1016/j.gaitpost.2018.03.039. Epub 2018 Apr 7.

PMID:
29660633
17.

Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease.

Minkova L, Gregory S, Scahill RI, Abdulkadir A, Kaller CP, Peter J, Long JD, Stout JC, Reilmann R, Roos RA, Durr A, Leavitt BR, Tabrizi SJ, Klöppel S; TRACK-HD Investigators.

Neuroimage Clin. 2017 Oct 25;17:312-324. doi: 10.1016/j.nicl.2017.10.023. eCollection 2018.

18.

Stimulating neural plasticity with real-time fMRI neurofeedback in Huntington's disease: A proof of concept study.

Papoutsi M, Weiskopf N, Langbehn D, Reilmann R, Rees G, Tabrizi SJ.

Hum Brain Mapp. 2018 Mar;39(3):1339-1353. doi: 10.1002/hbm.23921. Epub 2017 Dec 13.

19.

Quantitative examination of isometric tongue protrusion forces in children with oro-facial dysfunctions or myofunctional disorders.

Rohrbach S, Buettner F, Pollex D, Mathmann P, Weinhold L, Schubert R, Reilmann R.

J Oral Rehabil. 2018 Mar;45(3):228-234. doi: 10.1111/joor.12598. Epub 2018 Jan 18.

PMID:
29230834
20.

Brain Regions Showing White Matter Loss in Huntington's Disease Are Enriched for Synaptic and Metabolic Genes.

McColgan P, Gregory S, Seunarine KK, Razi A, Papoutsi M, Johnson E, Durr A, Roos RAC, Leavitt BR, Holmans P, Scahill RI, Clark CA, Rees G, Tabrizi SJ; Track-On HD Investigators.

Biol Psychiatry. 2018 Mar 1;83(5):456-465. doi: 10.1016/j.biopsych.2017.10.019. Epub 2017 Oct 26.

Supplemental Content

Loading ...
Support Center